Ömer Fatih Ölmez
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Inflammatory Biomarkers in Disease Prognosis, Lung Cancer Research Studies, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?(2015)
- → Predictive value of the modified Early Warning Score in a Turkish emergency department(2008)46 cited
- → GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients(2020)30 cited
- → The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme(2013)25 cited
- → The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study(2021)24 cited
- → Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer(2012)22 cited
- → Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy(2019)22 cited
- → Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer(2021)17 cited
- → Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab(2021)16 cited
- → Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis(2010)13 cited